DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,703,297 | +8.3% | 6,865 | +4.8% | 0.41% | +7.9% |
Q2 2023 | $1,572,584 | +17.6% | 6,552 | +22.4% | 0.38% | +7.6% |
Q1 2023 | $1,337,273 | +11.8% | 5,353 | +18.8% | 0.35% | +12.1% |
Q4 2022 | $1,195,665 | +7.5% | 4,505 | +4.6% | 0.32% | -4.5% |
Q3 2022 | $1,112,000 | -12.1% | 4,307 | -0.8% | 0.33% | +2.5% |
Q2 2022 | $1,265,000 | +116.6% | 4,341 | +118.0% | 0.32% | +130.0% |
Q1 2022 | $584,000 | +136.4% | 1,991 | +164.8% | 0.14% | +97.2% |
Q4 2021 | $247,000 | +7.9% | 752 | 0.0% | 0.07% | -5.3% |
Q3 2021 | $229,000 | +11.2% | 752 | -2.0% | 0.08% | +8.7% |
Q2 2021 | $206,000 | +1.0% | 767 | -16.4% | 0.07% | -36.1% |
Q4 2020 | $204,000 | +397.6% | 918 | +121.2% | 0.11% | +272.4% |
Q2 2018 | $41,000 | – | 415 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |